![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Interview by Tanya Stezhka
Dr Cooper-DeHoff is an Associate Professor in the Department of Pharmacotherapy and Translational Research, and the Department of Pharmaceutics in the College of Pharmacy, and in the Division of Cardiovascular Medicine, at the University of Florida (FL, USA). Her principle research focuses on hypertension, diabetes and the metabolic syndrome. She was a principle investigator of the INVEST study, which evaluated hypertension treatments in older coronary artery disease patients, and is currently a coinvestigator on two NIH grants evaluating pharmacogenetic hypertension associations. She is a member of the American Heart Association, American Society of Hypertension, American College of Cardiology and Florida Society of Hospital Pharmacists.
Disclaimer
The opinions expressed in this interview are those of the interviewee and do not necessarily reflect the views of Expert Reviews Ltd.
Financial & competing interests disclosure
The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.